Logo-hpp
2022: Two-year Impact Factor: 4.4
Scopus Journal Metrics
CiteScore (2022): 5.3
SNIP(2022):1.389
SJR(2022): 0.78
Platinum
Open Access

Health Promot Perspect. 2019;9(2): 92-98.
doi: 10.15171/hpp.2019.13
PMID: 31249795
PMCID: PMC6588804
Scopus ID: 85066852464
  Abstract View: 1925
  PDF Download: 1218
  Full Text View: 823

Systematic Review

A systematic review and meta-analysis on incidence of prostate cancer in Iran

Asaad Moradi 1, Mohammad Zamani 2,3 ORCID logo, Emadoddin Moudi 4,5* ORCID logo

1 Department of Urology, Firozgar Hospital, Iran University of Medical Sciences, Tehran, Iran
2 Student Research Committee, School of Medicine, Babol University of Medical Sciences, Babol, Iran
3 Cancer Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
4 Clinical Research Development Center, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, Iran
5 Department of Urology, Babol University of Medical Sciences, Babol, Iran
*Corresponding Author: Email: emadmoudi@gmail.com

Abstract

Background: Prostate cancer is a global health concern. In Iran, its epidemiology is not precisely recognized. We aimed to evaluate incidence of prostate cancer among Iranian populations. Methods: In this systematic review, we searched the databases PubMed, Web of Sciences, Scopus and Google Scholar for English studies and the databases Magiran, Scientific information Database, IranMedex and IranDoc for Persian studies, using related keywords. The cross sectional articles published from inception to 31 December 2018 were included. Meta-analysis was conducted on the collected data with STATA software using random effects model. Results: Out of 763 articles initially obtained, 9 articles were finally included after applying the predefined exclusion criteria. Analysis of 9 studies on the incidence of prostate cancer showed a crude rate of 7.1 per 100000 population (95% confidence interval [CI]: 5.6-8.6). Also, the pooled age-standardized incidence rate was 8.7 per 100000 (95% CI: 6.7-10.4). Studies performed in the period 2004-2012 had significantly a higher pooled estimate of the crude incidence rate (9.2 per 100000 [95% CI: 7.9-10.4]) compared with those conducted in the period 1996-2003 (4.5 per 100000 [95% CI: 2.8-6.2]). This trend was also observed based on the age-standardized incidence rate (11 per 100000 [95% CI: 9.4-12.5] versus 6.3 per 100000[95% CI: 4-8.5]).Conclusion: Despite low rate of prostate cancer occurrence in Iran, it is recommended that preventive measures be taken against this disease by health policymakers. Also, more epidemiological studies are needed to better find out the pattern of prostate cancer among Iranian populations.

Citation: Moradi A, Zamani M, Moudi E. A systematic review and meta-analysis on incidence of prostate cancer in Iran. Health PromotPerspect. 2019;9(2):92-98. doi: 10.15171/hpp.2019.13.
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 1926

Your browser does not support the canvas element.


PDF Download: 1218

Your browser does not support the canvas element.


Full Text View: 823

Your browser does not support the canvas element.

Submitted: 29 Oct 2018
Revision: 20 Mar 2019
Accepted: 27 Mar 2019
ePublished: 25 May 2019
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)